May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Periocular Injections of Triamcinolone for Posterior Recurrence of Vogt–Koyanagi–Harada Disease
Author Affiliations & Notes
  • T. Kaburaki
    Ophthalmology, Univ of Tokyo, School of Medicine, Bunkyo–Ku, Japan
  • S. Fujimura
    Ophthalmology, Univ of Tokyo, School of Medicine, Bunkyo–Ku, Japan
  • Y. Fujino
    Ophthalmology, Tokyo Kousei––Nenkin Hospital, Shinjuku–Ku, Japan
  • A. Yoshida
    Ophthalmology, Univ of Teikyo, School of Medicine, Itabashi–ku, Tokyo, Japan
  • J. Numaga
    Ophthalmology, Tokyo Geriatric Medical Center, Toshima–ku, Japan
  • M. Tubota
    Ophthalmology, Toho University the second hospital (Ohashi), Ota–ku, Japan
  • H. Kawashima
    Ophthalmology, Saitama Red Cross Hospital, Saitama, Japan
  • Footnotes
    Commercial Relationships  T. Kaburaki, None; S. Fujimura, None; Y. Fujino, None; A. Yoshida, None; J. Numaga, None; M. Tubota, None; H. Kawashima, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2427. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Kaburaki, S. Fujimura, Y. Fujino, A. Yoshida, J. Numaga, M. Tubota, H. Kawashima; Periocular Injections of Triamcinolone for Posterior Recurrence of Vogt–Koyanagi–Harada Disease . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2427.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : For posterior recurrence of Vogt–Koyanagi–Harada disease (VKHD), to increase the dosage of systemic corticosteroid or additional use of immunosuppressive agents is usually the choice of treatment conventionally. Now, we report three cases where posterior recurrences of VKHD were successfully treated by periocular triamcinolone injections without increasing or additional use of systemic immunosuppressive drugs.

Methods: : Cases are 53 year old (y.o.) woman, 65 y.o. man, and 35 y.o. man. All cases initially received corticosteroid pulse–therapy against VKHD that was followed with 40mg of oral prednisolone. All cases suffered from the recurrence of posterior uveitis type during tapering or after withdrawal of oral corticosteroids. The recurrence of posterior uveitis was diagnosed by the findings of fluorescein angiography (papillitis, multifocal leakage spots on retinal pigment epithelium) and optical coherence tomography (serous retinal detachment near the optic disc). The recurrence occurred on 82, 85, and 69 days after the corticosteroid pulse therapy, and the dosage of oral prednisolone at the time of recurrence was 15, 0, and 10mg/day, respectively. We performed 40mg of periocular triamcinolone injections without increasing dose of oral corticosteroid or additional use of immunosuppressants.

Results: : Serous retinal detachment disappeared in all cases within one or two weeks after periocular triamcinolone injections. No additional recurrences occurred in all cases, and oral prednisolone was gradually tapered in all cases without increasing the dosage.

Conclusions: : Periocular triamcinolone injections were effective for posterior recurrence in VKHD. This method may have a benefit of shortening the duration of oral corticosteroid usage for VKHD patients especially who suffer from posterior recurrences.

Keywords: uveitis-clinical/animal model • corticosteroids • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.